They also demonstrated that the VEGFR2-targeted nanoparticle could significantly enhance radiotherapy-mediated suppression of tumor growth and extend the lifespan of mice bearing ATC tumors compared with the corresponding non-targeted nanoparticle.91 This evidence concerns the gene KDR and neoplasm.